AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
CONTINUOUS MONITORING OF INTRATHECAL PO(2), PCO(2) AND PH DURING SURGICAL REPLACEMENT OF TYPE-II THORACOABDOMINAL AORTIC-ANEURYSM
Authors: CHRISTIANSSON L KARACAGIL S THELIN S HELLBERG A TYDEN H WIKLUND L BERGQVIST D
Citation: L. Christiansson et al., CONTINUOUS MONITORING OF INTRATHECAL PO(2), PCO(2) AND PH DURING SURGICAL REPLACEMENT OF TYPE-II THORACOABDOMINAL AORTIC-ANEURYSM, European journal of vascular and endovascular surgery, 15(1), 1998, pp. 78-81
USE OF A VITAL CAPACITY MANEUVER TO PREVENT ATELECTASIS AFTER CARDIOPULMONARY BYPASS - AN EXPERIMENTAL-STUDY
Authors: MAGNUSSON L ZEMGULIS V TENLING A WERNLUND J TYDEN H THELIN S HEDENSTIERNA G
Citation: L. Magnusson et al., USE OF A VITAL CAPACITY MANEUVER TO PREVENT ATELECTASIS AFTER CARDIOPULMONARY BYPASS - AN EXPERIMENTAL-STUDY, Anesthesiology, 88(1), 1998, pp. 134-142
HEMOSTASIS AT LOW HEPARIN DOSAGE DURING CARDIOPULMONARY BYPASS WITH HEPARIN-COATED CIRCUITS IN PIGS (VOL 31, PG 275, 1997)
Authors: BAGGE L BOROWIEC JW THELIN S HULTMAN J
Citation: L. Bagge et al., HEMOSTASIS AT LOW HEPARIN DOSAGE DURING CARDIOPULMONARY BYPASS WITH HEPARIN-COATED CIRCUITS IN PIGS (VOL 31, PG 275, 1997), SC CARDIOVA, 31(6), 1997, pp. 3
HEMOSTASIS AT LOW HEPARIN DOSAGE DURING CARDIOPULMONARY BYPASS WITH HEPARIN-COATED CIRCUITS IN PIGS
Authors: BAGGE L BOROWIEC JW THELIN S HULTMAN J
Citation: L. Bagge et al., HEMOSTASIS AT LOW HEPARIN DOSAGE DURING CARDIOPULMONARY BYPASS WITH HEPARIN-COATED CIRCUITS IN PIGS, SC CARDIOVA, 31(5), 1997, pp. 275-281
VARIABLE FHIT TRANSCRIPTS IN NONNEOPLASTIC TISSUES
Authors: PANAGOPOULOS I THELIN S MERTENS F MITELMAN F AMAN P
Citation: I. Panagopoulos et al., VARIABLE FHIT TRANSCRIPTS IN NONNEOPLASTIC TISSUES, Genes, chromosomes & cancer, 19(4), 1997, pp. 215-219
CLINICAL-EVALUATION OF DURAFLO(R)-II HEPARIN TREATED EXTRACORPOREAL-CIRCULATION CIRCUITS (2ND VERSION) - THE EUROPEAN WORKING GROUP ON HEPARIN COATED EXTRACORPOREAL-CIRCULATION CIRCUITS
Authors: WILDEVUUR CRH JANSEN PGM BEZEMER PD KUIK DJ EIJSMAN L BRUINS P DEJONG AP VANHARDEVELT FWJ BIERVLIET JD HASENKAM JM KURE HH KNUDSEN L BELLAICHE L AHLBURG P LOISANCE DY BAUFRETON C LEBESNERAIS P BAJAN G MATTA A VANDYCK M RENOTTE MT PONLOTLOIS A BAELE P MCGOVERN EA MCCARTHY J MCCARTHY A ODONNELL A FOSSE E MOEN O DREGELID E BROCKMEIER V ANDERSON C POMAR JL RANUCCI M CONTI D CIRRI S CONTI E DITTA A VONSEGESSER LK TKEBUCHAVA T WEISS BM TURINA MI SVENNEVIG JL MOHR B VIDEM V KARLSEN H PEDERSEN TH THELIN S HALDEN E HAGMAN L THORNO E AHLVIN E
Citation: Crh. Wildevuur et al., CLINICAL-EVALUATION OF DURAFLO(R)-II HEPARIN TREATED EXTRACORPOREAL-CIRCULATION CIRCUITS (2ND VERSION) - THE EUROPEAN WORKING GROUP ON HEPARIN COATED EXTRACORPOREAL-CIRCULATION CIRCUITS, European journal of cardio-thoracic surgery, 11(4), 1997, pp. 616-623
DURAFLO-II COATING OF CARDIOPULMONARY BYPASS CIRCUITS REDUCES COMPLEMENT ACTIVATION, BUT DOES NOT AFFECT THE RELEASE OF GRANULOCYTE ENZYMESIN FULLY HEPARINIZED PATIENTS - A EUROPEAN MULTICENTER STUDY
Authors: FOSSE E THELIN S SVENNEVIG JL JANSEN P MOLLNES TE HACK E VENGE P MOEN O BROCKMEIER V DREGELID E HALDEN E HAGMAN L VIDEM V PEDERSEN T MOHR B
Citation: E. Fosse et al., DURAFLO-II COATING OF CARDIOPULMONARY BYPASS CIRCUITS REDUCES COMPLEMENT ACTIVATION, BUT DOES NOT AFFECT THE RELEASE OF GRANULOCYTE ENZYMESIN FULLY HEPARINIZED PATIENTS - A EUROPEAN MULTICENTER STUDY, European journal of cardio-thoracic surgery, 11(2), 1997, pp. 320-327
THE PROTEIN CATALYZING THE CONVERSION OF D-DOPACHROME TO 5,6-DIHYDROXYINDOLE IS A PHENYLPYRUVATE TAUTOMERASE (EC-5.3.2.1)
Authors: ROSENGREN E THELIN S AMAN P HANSSON C JACOBSSON L RORSMAN H
Citation: E. Rosengren et al., THE PROTEIN CATALYZING THE CONVERSION OF D-DOPACHROME TO 5,6-DIHYDROXYINDOLE IS A PHENYLPYRUVATE TAUTOMERASE (EC-5.3.2.1), Melanoma research, 7(6), 1997, pp. 517-518
EXTENSIVE COAGULATION ACTIVATION AND CYTOKINE RELEASE IN SHED MEDIASTINAL BLOOD DURING HEART-SURGERY
Authors: ERNOFSSON M OLSSON C THELIN S SIEGBAHN A
Citation: M. Ernofsson et al., EXTENSIVE COAGULATION ACTIVATION AND CYTOKINE RELEASE IN SHED MEDIASTINAL BLOOD DURING HEART-SURGERY, Thrombosis and haemostasis, 1997, pp. 465-465
INDUCTION OF MONOCYTE TISSUE FACTOR EXPRESSION, THROMBIN FORMATION AND CYTOKINE RELEASE DURING HEART-SURGERY
Authors: SIEGBAHN A ERNOFSSON M THELIN S
Citation: A. Siegbahn et al., INDUCTION OF MONOCYTE TISSUE FACTOR EXPRESSION, THROMBIN FORMATION AND CYTOKINE RELEASE DURING HEART-SURGERY, Thrombosis and haemostasis, 1997, pp. 819-819
BIOCOMPATIBILITY REFLECTED BY HEMOSTASIS VARIABLES DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUITS
Authors: BOROWIEC J BAGGE L SALDEEN T THELIN S
Citation: J. Borowiec et al., BIOCOMPATIBILITY REFLECTED BY HEMOSTASIS VARIABLES DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUITS, The thoracic and cardiovascular surgeon, 45(4), 1997, pp. 163-167
HIGH-INCIDENCE OF CHLAMYDIA-PNEUMONIAE IN SCLEROTIC HEART-VALVES OF PATIENTS UNDERGOING AORTIC-VALVE REPLACEMENT
Authors: NYSTROMROSANDER C THELIN S HJELM E LINDQUIST O PAHLSON C FIRMAN G
Citation: C. Nystromrosander et al., HIGH-INCIDENCE OF CHLAMYDIA-PNEUMONIAE IN SCLEROTIC HEART-VALVES OF PATIENTS UNDERGOING AORTIC-VALVE REPLACEMENT, Scandinavian journal of infectious diseases, 29(4), 1997, pp. 361-365
MONOCYTE TISSUE FACTOR EXPRESSION, CELL ACTIVATION, AND THROMBIN FORMATION DURING CARDIOPULMONARY BYPASS - A CLINICAL-STUDY
Authors: ERNOFSSON M THELIN S SIEGBAHN A
Citation: M. Ernofsson et al., MONOCYTE TISSUE FACTOR EXPRESSION, CELL ACTIVATION, AND THROMBIN FORMATION DURING CARDIOPULMONARY BYPASS - A CLINICAL-STUDY, Journal of thoracic and cardiovascular surgery, 113(3), 1997, pp. 576-584
THE MACROPHAGE-MIGRATION INHIBITORY FACTOR MIF IS A PHENYLPYRUVATE TAUTOMERASE
Authors: ROSENGREN E AMAN P THELIN S HANSSON C AHLFORS S BJORK P JACOBSSON L RORSMAN H
Citation: E. Rosengren et al., THE MACROPHAGE-MIGRATION INHIBITORY FACTOR MIF IS A PHENYLPYRUVATE TAUTOMERASE, FEBS letters, 417(1), 1997, pp. 85-88
ATELECTASIS IS A MAJOR CAUSE OF HYPOXEMIA AND SHUNT AFTER CARDIOPULMONARY BYPASS - AN EXPERIMENTAL-STUDY
Authors: MAGNUSSON L ZEMGULIS V WICKY S TYDEN H THELIN S HEDENSTIERNA G
Citation: L. Magnusson et al., ATELECTASIS IS A MAJOR CAUSE OF HYPOXEMIA AND SHUNT AFTER CARDIOPULMONARY BYPASS - AN EXPERIMENTAL-STUDY, Anesthesiology, 87(5), 1997, pp. 1153-1163
UNTITLED
Authors: THELIN S MARKEWITZ A WALPOTH B LANDYMORE R MURDAY J
Citation: S. Thelin et al., UNTITLED, European journal of cardio-thoracic surgery, 10(1), 1996, pp. 67-67
EFFECTS OF HEPARIN COATING OF CARDIOPULMONARY BYPASS CIRCUITS ON IN-VITRO OXYGEN-FREE RADICAL PRODUCTION DURING CORONARY-BYPASS SURGERY
Authors: BOZDAYI M BOROWIEC J NILSSON L VENGE P THELIN S HANSSON HE
Citation: M. Bozdayi et al., EFFECTS OF HEPARIN COATING OF CARDIOPULMONARY BYPASS CIRCUITS ON IN-VITRO OXYGEN-FREE RADICAL PRODUCTION DURING CORONARY-BYPASS SURGERY, Artificial organs, 20(9), 1996, pp. 1008-1016
THE FHIT AND PTPRG GENES ARE DELETED IN BENIGN PROLIFERATIVE BREAST DISEASE-ASSOCIATED WITH FAMILIAL BREAST-CANCER AND CYTOGENETIC REARRANGEMENTS OF CHROMOSOME BAND 3P14
Authors: PANAGOPOULOS I PANDIS N THELIN S PETERSSON C MERTENS F BORG A KRISTOFFERSSON U MITELMAN F AMAN P
Citation: I. Panagopoulos et al., THE FHIT AND PTPRG GENES ARE DELETED IN BENIGN PROLIFERATIVE BREAST DISEASE-ASSOCIATED WITH FAMILIAL BREAST-CANCER AND CYTOGENETIC REARRANGEMENTS OF CHROMOSOME BAND 3P14, Cancer research, 56(21), 1996, pp. 4871-4875
THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUITS OR CONVENTIONAL CIRCUITS
Authors: ERNOFSSON M THELIN S SIEGBAHN A
Citation: M. Ernofsson et al., THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUITS OR CONVENTIONAL CIRCUITS, Thrombosis and haemostasis, 73(6), 1995, pp. 1344-1344
THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED OR STANDARD CIRCUITS
Authors: ERNOFSSON M THELIN S SIEGBAHN A
Citation: M. Ernofsson et al., THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS USING HEPARIN-COATED OR STANDARD CIRCUITS, Scandinavian journal of thoracic and cardiovascular surgery, 29(4), 1995, pp. 157-165
CIRCULATING CYTOKINES AND GRANULOCYTE-DERIVED ENZYMES DURING COMPLEX HEART-SURGERY - A CLINICAL-STUDY WITH SPECIAL REFERENCE TO HEPARIN-COATING OF CARDIOPULMONARY BYPASS CIRCUITS
Authors: BOROWIEC JW HAGMAN L TOTTERMAN TH PEKNA M VENGE P THELIN S
Citation: Jw. Borowiec et al., CIRCULATING CYTOKINES AND GRANULOCYTE-DERIVED ENZYMES DURING COMPLEX HEART-SURGERY - A CLINICAL-STUDY WITH SPECIAL REFERENCE TO HEPARIN-COATING OF CARDIOPULMONARY BYPASS CIRCUITS, Scandinavian journal of thoracic and cardiovascular surgery, 29(4), 1995, pp. 167-174
EOSINOPHIL GRANULE PROTEINS IN CARDIOPULMONARY BYPASS WITH AND WITHOUT HEPARIN COATING
Authors: NILSSON L PETERSON C VENGE P BOROWIEC JW THELIN S
Citation: L. Nilsson et al., EOSINOPHIL GRANULE PROTEINS IN CARDIOPULMONARY BYPASS WITH AND WITHOUT HEPARIN COATING, The Annals of thoracic surgery, 59(3), 1995, pp. 713-716
BIOCOMPATIBILITY OF HEPARIN-COATED CIRCUITS USED IN CARDIOPULMONARY BYPASS
Authors: PEKNA M BOROWIEC J FAGERHOL MK VENGE P THELIN S
Citation: M. Pekna et al., BIOCOMPATIBILITY OF HEPARIN-COATED CIRCUITS USED IN CARDIOPULMONARY BYPASS, Scandinavian journal of thoracic and cardiovascular surgery, 28(1), 1994, pp. 5-11
PAPILLARY FIBROELASTOMA AS AN UNUSUAL SOURCE OF REPEATED PULMONARY-EMBOLISM
Authors: WALTENBERGER J THELIN S
Citation: J. Waltenberger et S. Thelin, PAPILLARY FIBROELASTOMA AS AN UNUSUAL SOURCE OF REPEATED PULMONARY-EMBOLISM, Circulation, 89(5), 1994, pp. 2433-2433
COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EFFECTS OF IMMOBILIZED HEPARIN
Authors: PEKNA M HAGMAN L HALDEN E NILSSON UR NILSSON B THELIN S
Citation: M. Pekna et al., COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EFFECTS OF IMMOBILIZED HEPARIN, The Annals of thoracic surgery, 58(2), 1994, pp. 421-424
Risultati: 1-25 | 26-26